2Hypertension in older people:A National Clinical Guideline [ J ]. Scottish Intercollegate Guideline Network ,2001 ;49 : 19 - 30.
3Chobanian AV,Bakris GL,Black HR,et al. The seven report of the joint national committee on prevention, detection, evalution, and treatment of High Blood Pressure[ J]. JAMA,2003 ;289 (19) :2560 -72.
42003 European Society of Hypertension-European Society Cardiology guidelines for the management of arterial hypertension [ J ]. J Hypertens,2003 ;21 (6) : 1011 - 53.
5Guidelines Subcommittee of the WHO-ISH. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension [ J ]. J Hypertens, 1999 ; 17 (2) : 151 - 83.
6Ames RP. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides [ J]. Am J Cardiol, 1996:77 (6) : 12 - 6.
5[1]Ondetti M A,Rubin B,Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents[J]. Science, 1977,196: 441-444.
6[2]Ondetti M A,Cushman DW. Enzymes of the renin angiotensin system and their inhibitors[J].Annu Rev Biochem, 1982,51:283-308.
7[3]Cohen M L. Synthetic and fermentation-derived angiotensinconverting enzyme inhibitors[J].Annu Rev Pharmacol Toxicol,1985, 25: 307-323.
8[4]Leonetti G,Cuspidi C. Choosing the right ACE inhibitor-A guide to selection[J]. Drugs, 1995, 49(4): 516.
